Edward Prochownik, MD, PhD

Edward Prochownik, MD, PhD

University of Pittsburgh Physicians Director of Oncology Research, Children's Hospital of Pittsburgh Professor of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine Division of Pediatric Hematology/Oncology and Blood and Marrow Transplantation 4401 Penn Avenue, Floor 9 Pittsburgh, PA 15224 412-692-6795

University of Pittsburgh Physicians Director of Oncology Research, Children's Hospital of Pittsburgh Professor of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine Division of Pediatric Hematology/Oncology and Blood and Marrow Transplantation 4401 Penn Avenue, Floor 9 Pittsburgh, PA 15224 412-692-6795

Profile:

University of Pittsburgh Physicians

Director of Oncology Research, Children's Hospital of Pittsburgh

Professor of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine

4401 Penn Avenue, Floor 9

Pittsburgh, PA 15224

412-692-6795

Education and Training

Medical School:

1978 The University of Chicago Pritzker School of Medicine, Chicago, Ill.

Residency:

1980 Children's Hospital of Boston, Boston, Mass.

Fellowship:

1983 Children's Hospital of Boston Dana Farber Cancer Institute, Boston, Mass.

Board Certifications

American Board of PediatricsPediatric Hematology/OncologyPublications
Yap JL, Wang H, Hu A, Chauhan J, Jung KY, Gharavi RB, Prochownik EV, Fletcher S. Pharmacophore identification of c-Myc inhibitor 10074-G5. Bioorg Med Chem Lett. 2013 Jan 1;23(1):370-4.Kim SY, Rhee JG, Song X, Prochownik EV, Spitz DR, Lee YJ. Breast cancer stem cell-like cells are more sensitive to ionizing radiation than non-stem cells: role of ATM. PLoS One. 2012;7(11):e50423.Zhang F, Rothermund K, Gangadharan SB, Pommier Y, Prochownik EV, Lazo JS. Phenotypic screening reveals topoisomerase I as a breast cancer stem cell therapeutic target. Oncotarget. 2012 Sep;3(9):998-1010.

Edward Prochownik, MD, PhD